Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
09/20/1995 | EP0671944A1 Bovine pancreatic trypsin inhibitor derived inhibitors of factor viia-tissue factor complex |
09/20/1995 | EP0671936A1 TREATMENT OF INSULIN RESISTANCE IN OBESITY LINKED TYPE II DIABETES USING ANTAGONISTS TO TNF-$g(a) FUNCTION |
09/20/1995 | EP0671927A1 Human neutralizing monoclonal antibodies to respiratory syncytial virus |
09/20/1995 | EP0671909A1 Syndecan stimulation of cellular differentiation |
09/20/1995 | EP0671902A1 $i(CLOSTRIDIAL) TOXIN DISEASE THERAPY |
09/20/1995 | EP0671879A1 Prevention of retinal injury and degeneration by specific factors |
09/20/1995 | EP0652972A4 Pseudo-half-knot rna formation by hybridization of antisense oligonucleotides to target rna's secondary structure. |
09/20/1995 | EP0643778A4 Encoded combinatorial chemical libraries. |
09/20/1995 | EP0525095B1 HYBRIDIZATION PROBES DERIVED FROM THE SPACER REGION BETWEEN THE 16S AND 23S rRNA GENES FOR THE DETECTION OF NON-VIRAL MICROORGANISMS |
09/20/1995 | EP0474662B1 Bacillus thuringiensis gene, protein and its use |
09/20/1995 | EP0448635B1 Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus |
09/20/1995 | EP0415920B1 Monoclonal antibody specific to hiv antigens |
09/20/1995 | EP0326595B1 Peptides and antibodies that inhibit platelet adhesion |
09/20/1995 | CN1108695A Expression of e antigen in hay bacillus for hepatitis B virogene engineering |
09/20/1995 | CN1108694A 一种淡紫灰叶链霉菌dkrs菌株及用它制备阿克拉希霉素a,b,y和糖苷配基的方法 A lilac gray leaf dkrs Streptomyces strains and its preparation method Rashid Akbar ADM a, b, y and aglycone |
09/19/1995 | US5451664 Acta and methods for detecting the same |
09/19/1995 | US5451659 Polypeptide, DNA fragment encoding the same, drug composition containing the same and process for producing the same |
09/19/1995 | US5451522 Genes encoding and method of expressing an enzyme: phthalyl amidase |
09/19/1995 | US5451521 Procoagulant proteins |
09/19/1995 | US5451519 Cloning restriction endonuclease genes by modulating methyltransferase activity |
09/19/1995 | US5451517 And detection of Candida |
09/19/1995 | US5451516 Bifunctional protein from carrots (Daucus carota) with aspartokinase and homoserine dehydrogenase activities |
09/19/1995 | US5451514 Modification of lignin synthesis in plants |
09/19/1995 | US5451513 Method for stably transforming plastids of multicellular plants |
09/19/1995 | US5451512 Amplifying a region of the hla-a locus by polymerase chain reaction using oligonucleotide primers |
09/19/1995 | US5451506 Oncostatin M and novel compositions having anti-neoplastic activity |
09/19/1995 | US5451505 Detection and identification |
09/19/1995 | US5451503 Method for use of branched nucleic acid probes |
09/19/1995 | US5451500 Device for processing biological specimens for analysis of nucleic acids |
09/19/1995 | US5451499 Attenuated, genetically-engineered pseudorabies virus S-PRV-155 and uses thereof |
09/19/1995 | US5451399 [ALA IL-8]77 and [SER IL-8]72 as Leukocyte adhesion inhibitors |
09/19/1995 | CA1337050C Monoclonal antibody selectively binding to novel g-csf derivative |
09/19/1995 | CA1337048C Process for the production of biologically active peptide via the expression of modified storage seed protein genes in transgenic plants |
09/15/1995 | CA2143365A1 Nucleic acid amplification method and apparatus |
09/14/1995 | WO1995024649A1 Binding assay using binding agents with tail groups |
09/14/1995 | WO1995024506A1 Methods of identifying inducible inhibitors of transformation progression |
09/14/1995 | WO1995024504A1 Combined use of genetic markers for the diagnosis of alzheimer's disease, diagnostic kit and method |
09/14/1995 | WO1995024501A1 Compositions for the inhibition of tnf formation and uses thereof |
09/14/1995 | WO1995024499A1 Method for suppressing inhibition of enzyme-mediated reactions by ionic detergents |
09/14/1995 | WO1995024495A1 Transgenic production of oligosaccharides and glycoconjugates |
09/14/1995 | WO1995024494A1 Humanized milk |
09/14/1995 | WO1995024493A1 Enhanced expression in a plant plastid |
09/14/1995 | WO1995024492A1 Expression of bacillus thuringiensis cry proteins in plant plastids |
09/14/1995 | WO1995024491A1 Combined use of two expression cassettes for the production of a useful protein |
09/14/1995 | WO1995024490A1 Cell surface protein and effector cell bonding reagent |
09/14/1995 | WO1995024489A1 Targeted cleavage of rna using ribonuclease p targeting and cleavage sequences |
09/14/1995 | WO1995024488A1 Transgenic animals producing oligosaccharides and glycoconjugates |
09/14/1995 | WO1995024487A1 Processes for inhibiting and for inducing flower formation in plants |
09/14/1995 | WO1995024486A1 ANTIMICROBIAL PROTEINS FROM ARALIA AND $i(IMPATIENS) |
09/14/1995 | WO1995024485A2 Coordinate in vivo gene expression |
09/14/1995 | WO1995024483A1 Recombinant humanized anti-fb5 antibodies |
09/14/1995 | WO1995024481A2 Humanized monoclonal antibodies against human interleukin-4 |
09/14/1995 | WO1995024480A1 Fk506-binding protein gene |
09/14/1995 | WO1995024479A1 Novel thiol protease inhibitor |
09/14/1995 | WO1995024478A1 Synthetic proteins as implantables |
09/14/1995 | WO1995024477A1 Human papillomavirus targeted ribozymes |
09/14/1995 | WO1995024476A1 Method of cloning |
09/14/1995 | WO1995024475A1 Vaccine compositions |
09/14/1995 | WO1995024473A1 Vascular endothelial growth factor 2 |
09/14/1995 | WO1995024470A1 Activating virus |
09/14/1995 | WO1995024469A1 Extracorporeal cell culture and transplantation kits |
09/14/1995 | WO1995024466A1 Transforming growth factor alpha h1 |
09/14/1995 | WO1995024427A1 Hybrid human/animal factor viii |
09/14/1995 | WO1995024426A1 A novel expression-cloning method for identifying target proteins for eukaryotic tyrosine kinases and novel target proteins |
09/14/1995 | WO1995024423A1 Insect neuropeptides |
09/14/1995 | WO1995024419A1 Methods and materials for identifying inhibitors of molecular interactions mediated by sh3 domains |
09/14/1995 | WO1995024414A1 Fibroblast growth factor-10 |
09/14/1995 | WO1995024411A1 Corpuscles of stannius protein, stanniocalcin |
09/14/1995 | WO1995024224A1 Murine model for human immunodeficiency virus (hiv) disease |
09/14/1995 | WO1995024223A1 Inhibition of cell proliferation by e2f-1 antisense oligonucleotides |
09/14/1995 | WO1995024221A1 Bioactive and/or targeted dendrimer conjugates |
09/14/1995 | WO1995024214A1 Para-influenza virus-containing vaccines for preventing porcine reproductive and respiratory syndrome |
09/14/1995 | WO1995024209A1 Therapeutic uses of bactericidal/permeability-increasing protein dimer products |
09/14/1995 | WO1995024208A1 Glioblastoma-derived angiogenesis inhibiting factor |
09/14/1995 | WO1995024202A1 Ribozyme therapy for restenosis |
09/14/1995 | WO1995024198A1 DIROFILARIA IMMITIS Gp29 PROTEINS, NUCLEIC ACID MOLECULES AND USES THEREOF |
09/14/1995 | WO1995024185A1 Novel pyrimidine nucleosides |
09/14/1995 | WO1995024182A1 Human osteoclast-derived cathepsin |
09/14/1995 | WO1995006128A3 Fertile, transgenic maize plants and methods for their production |
09/14/1995 | WO1995003406A3 Enhancement of oligonucleotide inhibition of protein production, cell proliferation, and/or multiplication of infectious disease pathogens |
09/14/1995 | DE4447472A1 Sequences for proteins with saccharose-isomerase activity |
09/14/1995 | DE4408629A1 Inhibiting citrate synthase (CS) activity in plants |
09/14/1995 | DE4407489A1 Vakzine zur Prävention von Respirations- und Reproduktionserkrankungen des Schweines Vaccine for the prevention of respiratory and reproductive diseases of the pig |
09/14/1995 | CA2565191A1 Enhanced expression in a plant plastid |
09/14/1995 | CA2443236A1 Human osteoclast-derived cathepsin |
09/14/1995 | CA2414016A1 Vascular endothelial growth factor 2 |
09/14/1995 | CA2185327A1 Hybrid human/animal factor viii |
09/14/1995 | CA2185238A1 Methods of identifying inducible inhibitors of transformation progression |
09/14/1995 | CA2185162A1 Compositions for the inhibition of tnf formation and uses thereof |
09/14/1995 | CA2185117A1 Targeted cleavage of rna using ribonuclease p targeting and cleavage sequences |
09/14/1995 | CA2185116A1 Recombinant humanized anti-fb5 antibodies |
09/14/1995 | CA2185103A1 Combined use of two expression cassettes for the production of a useful protein |
09/14/1995 | CA2185097A1 Activating virus |
09/14/1995 | CA2184989A1 Ribozyme therapy for restenosis |
09/14/1995 | CA2184988A1 A novel expression-cloning method for identifying target proteins for eukaryotic tyrosine kinases and novel target proteins |
09/14/1995 | CA2184905A1 Corpuscles of stannius protein, stanniocalcin |
09/14/1995 | CA2184902A1 Vaccine compositions |
09/14/1995 | CA2184833A1 Para-influenza virus-containing vaccines for preventing porcine reproductive and respiratory syndrome |
09/14/1995 | CA2184741A1 Processes for inhibiting and for inducing flower formation in plants |
09/14/1995 | CA2184688A1 Transgenic animals producing oligosaccharides and glycoconjugates |